Related Experiment Video

Updated: Jul 10, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

Epidemiology and genetics of calcific aortic valve disease

Kevin D O'Brien1

  • 1Division of Cardiology, University of Washington, Seattle, WA 98195-6422, USA. cardiac@u.washington.edu

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|October 30, 2007
PubMed

Insights

Calcific aortic valve disease, common in the elderly, lacks proven pharmacologic treatments. Research explores novel risk factors and genetics, suggesting nonatherosclerotic pathways for new therapeutic strategies.

Area of Science:

  • Cardiology
  • Geriatrics
  • Genetics

Background:

  • Calcific aortic valve disease (CAVD) is a prevalent condition in older adults, leading to significant illness and death.
  • While lipoproteins and the renin-angiotensin system are implicated, no drug has proven effective in slowing CAVD progression in controlled trials.

Purpose of the Study:

  • To review the stages of calcific aortic valve disease.
  • To discuss advanced imaging techniques for early detection.
  • To summarize current knowledge on risk factors, including genetics, and potential therapeutic targets.

Main Methods:

  • Literature review of calcific aortic valve disease stages and epidemiology.
  • Analysis of studies utilizing non-echocardiographic imaging, such as cardiac CT.
  • Synthesis of research on novel risk factors (metabolic syndrome, inflammation) and genetic influences.

Main Results:

  • Cardiac computed tomography aids in identifying early-stage disease.
  • Metabolic syndrome, inflammation, and genetic factors play significant roles.
  • Nonatherosclerotic pathways are increasingly recognized in CAVD pathogenesis.

Conclusions:

  • Understanding CAVD progression requires considering diverse factors beyond traditional atherosclerosis.
  • Genetic polymorphisms and single-gene defects offer insights into disease mechanisms.
  • Novel therapeutic strategies targeting unique nonatherosclerotic pathways are promising for CAVD treatment.

More Related Videos

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Isolation of Human Primary Valve Cells for In vitro Disease Modeling07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...